Record Awaiting Appraisal

Zhelnov P. A critical appraisal of ‘Nasser NJ, Gorenberg M, Agbarya A. First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals (Basel). 2020 Nov 8;13(11):E373. doi: 10.3390/ph13110373. PMID: 33171686’. Zheln. 2020 Nov 14;46(2):r413d12. URI: https://zheln.com/record/2020/11/12/413/.

Zheln Review Appraisal in 10 Steps:

1. ✅ Downloaded from the PubMed Systematic Subset Daily Updates
2. 🔄 Meets Shojania & Bero 2001 True Positive Criteria for Systematic Reviews by Either Title or Abstract?
3. 🔄 Full Text or Other Reports Collected by Zheln
4. 🔄 Generates Pragmatic Evidence Directly Relevant to Evidence-Based Practice?
5. 🔄 Is Duplicate?
6. 🔄 Passed or Failed Replication?
7. 🔄 Has Critical Conduct Flaws?
8. 🔄 Liked or Disliked by Zheln?
9. 🔄 Practical Implications Summarized by Zheln
10. 🔄 Appraisal Published & Call for Crowdfunding

I have uploaded this record from PubMed but haven’t appraised it yet.

If you want me to appraise this record, I’ve got several options for you:

• Wait until I get my hands on it myself.
• Buy a subscription on Patreon, GitHub Sponsors, or Open Collective for $1 to $600 and PM me with the review request.
• Send me $1 via PayPal with this reference in the message, and I’ll happily appraise it for you.
• Contact me by email or on Twitter, Facebook, Instagram, or Telegram, and I’m sure we’ll find a way around.